clearance from the coronary lumen and, therefore, requires the use of contrast media. 1, 2 OCT is unable to penetrate and see throughout red thrombus (that casts major dorsal shadowing) whereas IVUS is unable to see through heavily calcified plaques. IVUS has a deeper penetration on the vessel wall and, therefore, is better suited to detect the external elastic lamina, particularly in the presence of a large plaque burden. Alternatively, OCT offers pristine images of the lumen-intima interface and yields near histological details of the superficial aspects of plaques but remains relatively 'short-sighted' to assess fully bulky plaques especially in large vessels. 1, 2 Studies have demonstrated the superior accuracy of OCT to measure lumen areas compared with IVUS that slightly overestimates lumen measurements. Following stent implantation, IVUS is able readily to detect stent underexpansion, malapposition, plaque/thrombus prolapse, and edge dissections.
1,2 These problems, typically angiographically silent, can be addressed and tackled during the procedure as required. 1, 2 During the last two decades a large body of evidence has been accumulated supporting the clinical value of IVUS guidance, compared with classical angiographic guidance, to optimize stent implantation and, eventually, to improve long-term clinical outcomes. 3 Accordingly, revascularization guidelines suggest (recommendation IIa, level of evidence B) the usefulness of IVUS guidance in selected patients undergoing coronary stenting, including those with left main disease. 3 OCT is by far superior to IVUS in detecting subtle morphological abnormalities after stent implantation, including minor plaque prolapse, tiny intraluminal thrombus, minor degrees of malapposition, and small edge dissections ( Figure 1 ). 1,2 However, the clinical implications of these 'minor' abnormalities (only detectable by OCT) currently remain unclear. Accordingly, mainly as a result of the shorter clinical experience and the limited available evidence, current guidelines support the value of OCT guidance for stent optimization, but only with a IIb recommendation, level of evidence C. 3 Both techniques, however, are considered equally useful in the management of patients presenting with stent failure, namely in-stent restenosis and stent thrombosis (recommendation IIa, level of evidence C). 3 
Current study
In this issue of the journal, Kubo et al. 4 present a study that sought to compare OCT with IVUS guidance in patients treated with second-generation drug-eluting stents (DES). The OPINION trial included 829 patients from 42 medical centres in Japan that were randomly allocated to OCT-guided (n = 414) or IVUS-guided (n = 415) DES implantation. The primary endpoint, non-inferiority of OCT guidance vs. IVUS guidance regarding target lesion failure (a composite of cardiac death, target vessel myocardial infarction, and ischaemia-driven target vessel revascularization) at 1 year, 5.2% vs. 4.9% respectively, was met (P for non-inferiority 0.042). In addition, with nearly 90% of late angiographic follow-up, the binary restenosis rate [in-stent (1.6% vs. 1.6%) and in-segment (6.2% vs. 6.0%)] was also similar in the two arms. These investigators concluded that both imaging strategies yielded similar excellent long-term clinical and angiographic outcomes. investigators should be commended for this study, which is timely, nicely executed, methodologically sound, and with robust results. Due to the important clinical implication of these findings, some issues should be discussed.
First, in the OCT arm, stent diameter was determined by measuring lumen diameters at proximal and distal reference segments. On the other hand, in the IVUS arm, stent diameter was determined according to total vessel diameter (approximated by the external elastic membrane). Although this approach widely reflects routine clinical practice, 1,2 it means that the two imaging techniques are aimed at a different target. The results might have been different had the same measurements been used to select stent size with both strategies. Notably, recent studies suggest that, in most patients, OCT can also identify the external elastic lamina in reference segments for sizing purposes ( Figure 1 ).
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As a consequence, stent diameter and in-stent acute gain were significantly smaller in the OCT-guided group compared with the IVUSguided group. Moreover, at baseline, a non-significant trend for a larger minimal diameter was found in the OCT arm, whereas a trend in the opposite direction was found at follow-up. Whether these results are a consequence of the different targets used to select stent diameters (lumen with OCT, external elastic lamina with IVUS) remains unclear. Reassuringly, however, in-stent and in-segment binary restenosis rates were very low and similar with the two strategies.
Secondly, after stent implantation, additional procedures were performed, if deemed safe and feasible, when features with the potential to provoke flow disturbances (including incomplete stent expansion or apposition, asymmetric expansion, plaque or thrombus protrusion, or edge dissections) were identified. The large clinical experience of these Japanese investigators with OCT empowered them to make adequate image-based clinical decisions during stent optimization. However, the external generalizability of this pragmatic, non-prescriptive strategy, to other centres with less OCT experience, or to more complex patient and lesion subsets, remains unclear. Further studies are warranted to define further the best qualitative and quantitative morphological criteria that should be used during stent optimization, not only from an acute anatomic or functional perspective but, more importantly, regarding long-term clinical outcomes.
Thirdly, more than one-third of patients in each arm required additional post-dilation with larger balloons or higher pressures driven by findings disclosed by intracoronary imaging. Unfortunately, however, a detailed analysis of OCT and IVUS findings during the procedure, immediately after the intervention, and at late follow-up, was not performed.
Fourthly, the selected non-inferiority margin for target vessel failure (7%) may be criticized, yet the final sample size was the largest ever obtained in this type of comparative study, and, reassuringly, the long-term clinical and angiographic results were remarkably similar.
Fifthly, patients and investigators were not masked to allocation. Nevertheless, it is difficult to anticipate how this could affect the study results as repeated revascularization required the presence of ischaemia, and events were blindly adjudicated. Likewise, although a per-protocol analysis is recommended in non-inferiority trials, the intention to treat sensitivity analysis, also presented in this study, yielded consistent results.
Finally, as only biolimus DES were used in both arms of this trial, it could be argued that the results might not be extrapolated to 
Previous studies
Optical coherence tomography-guided stent optimization has been associated with improved acute results as compared with angiographic guidance alone.
1,2,5-10 In addition, OCT provides unique visualization of the healing process after stenting that may be considered as a surrogate marker of DES safety and efficacy. 1,2 Furthermore, previous observational studies suggested that OCT-guided stent optimization could improve long-term clinical outcomes. 6, 7 A large Italian registry-reinforced by the use of propensity score analysis-suggested that OCT guidance could reduce the rate of cardiac death or myocardial infarction compared with angiographic guidance. 6 ILUMIEN I was a prospective registry including 418 patients treated under documentary OCT and fractional flow reserve before and after intervention. 8 Although the protocol was not prescriptive, preand post-stenting OCT findings led to modification of the treatment strategy in 57% and 27% of lesions, respectively. 8 ILUMIEN II was a retrospective post-hoc analysis comparing 286 pairs of propensitymatched lesions from two previous studies of DES implantation under OCT and IVUS guidance. 9 The study demonstrated that the degree of stent expansion achieved with both techniques (72.8% vs. 70.6%) was similar. 9 Underexpansion is widely accepted as a major factor influencing long-term clinical outcomes. 1, 2 However, the precise criteria to consider morphological abnormalities of potential clinical relevance and, therefore, requiring to be tackled, remain unsettled. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] In most studies, the operator was left with the decision to react to or leave untreated the problems disclosed by OCT according to ill-defined standards or simply subjective criteria. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] In addition, most of these studies were retrospective and observational in nature, and, therefore, highly vulnerable to selection bias and confounding. Finally, they included a relatively small number of patients and had a limited clinical follow-up. On the other hand, the value of OCT to unravel potential culprit mechanisms in patients suffering from in-stent restenosis or stent thrombosis has been demonstrated. [11] [12] [13] Several underlying acute mechanical problems (incomplete lesion coverage, underexpansion, malapposition, edge disease, or dissections) but also late issues, such as delayed healing, lack of strut coverage, or complicated neoatherosclerosis, have been proposed as potential mechanisms leading to stent failure. [1] [2] [3] [11] [12] [13] However, these worrisome findings frequently detected in patients suffering from stent-related events should be balanced against data coming from other large studies with long-term follow-up demonstrating that most patients with intracoronary image-detected mechanically abnormalities do not experience any clinical complication. In the largest registry published so far, minimal stent area, narrowing at reference segments, and edge dissections (>200 lm) were variables related to a poor outcome.
14 Other findings such as malapposition and residual stent narrowing were not predictors of adverse events. Further studies are warranted to reconcile these apparently contradictory data that, like the two faces of Janus, still generate confusion and controversy. Fortunately enough, evidence stemming from randomized clinical trials is also rapidly growing. 5, [15] [16] [17] In a single-centre randomized study, Habara et al. allocated 70 lesions to either OCT-(n = 35) or IVUS-guided (n = 35) stenting. 15 The final minimal lumen area and stent expansion were significantly lower in the OCT arm. However, in this study, the post-dilation strategy was largely based on the external elastic lamina measurement at the minimum stent area which was only obtained in 11% of patients in the OCT arm vs. 94% in the IVUS group. This could help to explain the inferior results in the OCT arm. 15 In another small randomized trial, Kim et al. allocated 105
lesions to be treated with DES under OCT guidance (n = 51) or angiography guidance alone (n = 54). 16 The primary endpoint (percentage of uncovered struts on OCT at 6 months) was significantly lower in the OCT arm that also less frequently showed late malapposition. 16 The DOCTORS randomized clinical trial allocated 240 patients with non-ST-segment elevation acute coronary syndrome from nine hospitals in France to OCT-guided (n = 120) vs. angioguided (n = 120) DES implantation. 17 OCT findings led to a change in the initial strategy in 50% of patients, resulting in a more frequent use of post-dilation (43% vs. 12.5%, P < 0.0001) and a lower angiographic residual stenosis (7 ± 4.3 vs. 8.7 ± 6.3%, P = 0.01) compared with the angiographic-guided arm. The primary study endpoint, the fractional flow reserve post-intervention, was significantly higher (0.94 ± 0.04 vs. 0.92 ± 0.05, P = 0.005) in the OCT arm. Notably, OCT-guided post-dilation significantly improved final minimal stent area and stent expansion. These benefits, however, were obtained at the expense of longer procedures, higher fluoroscopy time, and larger contrast volume in the OCT arm. 17 Very recently, the larger ILUMIEN III randomized clinical trial allocated 450 patients to OCT (n = 158), IVUS (n = 146), or angiographic guidance alone (n = 140). 5 A final
OCT acquisition was mandated in the three arms in order to document final results. In this study, a novel strategy, namely the use of OCT to identify the external elastic lamina at the reference segments, was successfully used to select stent size. ) was met (P = 0.001). Moreover, compared with the angiographic arm, OCT guidance was associated with a lower incidence of malapposition and residual dissections. 5 Although all these previous controlled studies on OCT guidance selected attractive surrogate endpoints, none of them was powered for clinical outcomes.
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Final remarks
The OPINION trial, the first controlled study powered for clinical endpoints, provides compelling evidence supporting the clinical value of OCT guidance compared with IVUS guidance. 4 However, additional studies are still required to confirm that this strategy translates into superior long-term clinical outcomes compared with classic angiographic guidance. In addition, the clinical implications of mild residual mechanical problems and the precise criteria to be used during stent optimization should be further refined. 1,2 Finally, more information is required to identify the subsets of patients and lesions most likely to obtain clinical benefit from OCT-guided DES implantation.
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